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Abstract We have identi¢ed Sti, the gene of a ribonuclease
inhibitor from Saccharopolyspora erythraea, by using a T7
phage display system. A speci¢c phage has been isolated from
a genome library by a biopanning procedure, using RNase Sa3,
a ribonuclease from Streptomyces aureofaciens, as bait. Sti, a
protein of 121 amino acid residues, with molecular mass 13 059
Da, is a homolog of barstar and other microbial ribonuclease
inhibitors. To overexpress its gene in Escherichia coli, we opti-
mized the secondary structure of its mRNA by introducing a
series of silent mutations. Soluble protein was isolated and pu-
ri¢ed to homogeneity. Inhibition constants of complex of Sti and
RNase Sa3 or barnase were determined at pH 7 as 5U10312 or
7U1037, respectively.
, 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
For some years, considerable interest has been focused on
barnase and barstar, the extracellular ribonuclease and its
protein inhibitor from Bacillus amyloliquefaciens, addressing
problems of protein folding and protein recognition [1]. Many
bacterial and fungal homologs of barnase have been identi-
¢ed, with essentially the same fold but with widely disparate
sequences, providing clues as to just what elements of the
sequence determine the fold. Presumably, homologs of barstar
could be useful in the same manner. Barstar was unique until
the ¢rst ribonuclease inhibitors from Streptomyces aureofa-
ciens were cloned in 1998 [2]. Some putative ribonuclease in-
hibitors have been identi¢ed in genomes of bacteria within
microbial genome sequencing projects and here we report
the cloning and expression of another.
It is well known that barstar forms a very tight complex
with barnase (Kd = 10314 M) as well as with barnase strepto-
mycete homologs [3]. In spite of rather low sequence homol-
ogy (22^27%) of streptomycete ribonucleases with barnase,
there is a high structural similarity in their active sites. RNase
Sa, the extracellular ribonuclease produced by S. aureofaciens,
strain BMK, forms almost identical contacts with barstar as
does barnase [4]. This has allowed the construction of plas-
mids in Escherichia coli containing the genes of both barstar
and the streptomycete ribonucleases, with secretion of these
ribonucleases on a scale of several tens of milligrams [3]. For
another homolog of barnase, RNase St, the barstar gene pro-
vides some protection for E. coli from its gene expression but
not enough to allow production of useful amounts of the
enzyme [3]. RNase St [5] is secreted by an organism originally
called Streptomyces erythreus but reclassi¢ed as Saccharopo-
lyspora erythraea by Labeda [6]. The amino acid sequences of
RNases Sa and St are about 20% identical to that of barnase
and 40% to each other. A superimposition of tertiary struc-
tures of barnase with RNase St or RNase Sa reveals larger
values of root mean square and maximum deviations for
RNase St than for RNase Sa [3]. Additionally, since the ionic
residues of barstar contributing to binding to ribonuclease are
all negatively charged, it has been speculated that the high
negative charge on RNase St (pI=3.9) can cause a slower
association rate with barstar (J. Sevcik, personal communica-
tion). As mutational and theoretical examinations of the bar-
nase^barstar complex have implied, barstar’s distribution of
charged residues is well optimized for rapid and tight binding
to barnase [7,8]. It has also been demonstrated that, in the
case of barnase^barstar, electrostatic forces increase basal as-
sociation rates by more than four orders of magnitude from
105 to 5U109 M31 s31 [9]. Based on theoretical and experi-
mental work on the barnase^barstar complex, it seems likely
that formation of a complex of RNase St and barstar is ag-
gravated by unfavorable steric and electrostatic complemen-
tarities.
We have cloned and expressed the gene (Sti) of a ribonu-
clease inhibitor from S. erythraea. We demonstrate that Sti is
a homolog of barstar and other microbial ribonuclease inhib-
itors. Its expression did not immediately lead to large scale
production of RNase St in E. coli but it may be a step in that
direction.
2. Materials and methods
2.1. Bacterial strains and vectors
S. erythraea, strain NRRL 2338, was used for genomic DNA iso-
lation. T7 phage was grown on BLT5403 (Novagen). XL1-Blue MRFP
(Stratagene) was used for plasmid DNA preparation. BL21(DE3)-
pLysS and Turner (DE3)pLacI (Novagen) were used for protein pro-
duction. T7Select10-3b (Novagen) and pUC18 were used for construc-
tion of genomic library. pET28a and pET Blue-2 (Novagen) were used
for overexpression of Sti gene in E. coli.
2.2. Construction of T7 phage display library
All DNA manipulations were performed using standard methods
[10]. Genomic DNA was isolated and puri¢ed from S. erythraea ac-
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cording to Hopwood [11]. T7 phage DNA was isolated according to
instructions of the manufacturer. The shotgun phage display library
was constructed as follows: genomic DNA was fragmented randomly
by sonication and fragments of 300^700 bp were isolated by prepara-
tive gel electrophoresis and made blunt-ended using mung bean nu-
clease. Phage vector was digested with the restriction enzyme SmaI
and dephosphorylated with calf intestinal alkaline phosphatase. Liga-
tion was carried out at 16‡C overnight in presence of 5% PEG 8000.
DNA was packaged in vitro using T7Select packaging extract (Nova-
gen) and ampli¢ed before use in a liquid culture by infecting mid-log
phase BLT 5403 E. coli cells. An average insert size and percentage of
recombinant phages were determined by polymerase chain reaction
(PCR) of a number of randomly chosen plaques with sense primer
T3 5P-GACCAGATTATCGCTAAGTACGCAATG and the anti-
sense primer T4 5P-GTTCACCGATAGACGCCAGAATGTC.
2.3. Phage a⁄nity selection
Target ligands ^ barnase (extracellular ribonuclease from B. amy-
loliquefaciens) and RNase Sa3 (extracellular ribonuclease from S. aur-
eofaciens, strain 3239) ^ were coupled to Iontosorb AV cellulose (Ion-
tosorb) as described previously [2]. For phage binding experiments,
300 Wl of a⁄nity resin was packed into a column of 6 mm diameter.
For the ¢rst round of biopannig 8 ml of phage lysate (V order of 1010
pfu) was applied at a £ow rate of 10 ml h31. The column was washed
with 50 ml of 0.5 M NaCl, 20 mM Tris^HCl (pH 8) to remove non-
speci¢c binding phage and ribonuclease-bound phage was eluted by
1 ml of 0.5% sodium dodecyl sulfate (SDS) in the same bu¡er. Before
subsequent ampli¢cation of phage, SDS was removed by precipitation
with 1/10 volume of 10 M KAc on ice [12]. The column was washed
with another 10 ml of elution bu¡er followed by 50 ml of washing
bu¡er and used in next round. The entire procedure was repeated ¢ve
more times; 2 ml of ampli¢ed phage was taken from previous rounds
of panning.
2.4. DNA sequencing
The DNA sequences of phage inserts were determined after PCR
ampli¢cation by automatic sequencing on an Applied Biosystems 373
Sequencer by using Big Dye chemistry (PE Applied Biosystems). Se-
quencing was performed in both directions.
2.5. Cloning the gene of inhibitor Sti from subgenomic plasmid library
This was carried out in order to con¢rm the 5P and 3P sequences
surrounding the Sti structural gene and to avoid mutations introduced
by PCR. S. erythraea genomic DNA was digested with a variety of
restriction endonucleases and Southern blot analysis was performed
using as a probe a PCR-ampli¢ed insert from a selected phage clone
already identi¢ed by sequencing as a homolog of barstar. A 2.1 kb Sti
fragment was cloned into pUC 18 vector and a positive clone was
identi¢ed by hybridization with the 32P-labelled probe.
2.6. Expression of the Sti gene in E. coli
Cloning restriction sites at 5P- end and 3P- end of Sti gene were
created by PCR ampli¢cation of the gene using sense primer 5P-GAA-
GAAGAAGAACCATGGGCGGGTTGGAGGAACCCTCC carry-
ing NcoI restriction site and antisense primer 5P-AAGAAGAAGAA-
GAAGCTTTCAGTTCCGGGTCAGGACCGC containing HindIII
restriction site, which allowed in-frame insertion of the Sti gene into
both pET28a and pET Blue-2 expression vectors. The ampli¢ed frag-
ment was digested with NcoI and HindIII and ligated into the vector
digested with the same restriction endonucleases to yield pETSti or
pETBluSti, respectively. pETSti was transformed into BL21(DE3)-
LysS E. coli strain; E. coli Turner(DE3)LacI was used for expression
of Sti from pETBlueSti plasmid. LB medium supplemented with cor-
responding antibiotics was inoculated with a single colony and grown
at 37‡C until the absorbance value at 600 nm reached 0.5. Three ml of
this culture was used to inoculate 100 ml of SB medium and grown to
reach about 0.8 OD600. The expression of protein was induced by
adding IPTG to ¢nal concentration 1 mM and incubation extended
at 37‡C overnight.
2.7. Isolation and puri¢cation of recombinant Sti
Bacterial cells were harvested and soluble proteins were released by
suspension of a cell pellet in BugBuster protein extraction reagent,
supplemented with benzonase nuclease (Novagen) and incubated at
room temperature for 20 min. Insoluble cell debris were removed by
centrifugation. Nucleic acids were precipitated with streptomycin sul-
fate at ¢nal concentration 1.5%. The supernatant was clari¢ed by
centrifugation and diluted with an equal volume of 20 mM Tris^
HCl, pH 7.2, 20 mM mercaptoethanol, 1 mM EDTA (bu¡er A),
and applied onto HiPrep 16/10 Q XL Sepharose column (Amersham
Biosciences), using HiTrap Sepharose Q FF 5 ml connected in series
as a precolumn. After washing the column, Sti was eluted with a
linear gradient of elution bu¡er (bu¡er A with 0.7 M NaCl). Fractions
containing Sti inhibitor were collected, concentrated using Centriprep
YM3 (Amicon) and applied further on 16/60 Superdex-75 size-exclu-
sion column (Amersham Biosciences). Protein was eluted with 50 mM
sodium bicarbonate, 20 mM mercaptoethanol.
2.8. Prediction of mRNA secondary structure
Analysis of potential secondary structure adopted by mRNA se-
quence was carried out using the program mfold [13].
2.9. Determination of inhibition constants
Determination of ribonuclease-inhibitor dissociation constants was
performed basically as described previously [12]. In short, measure-
ments of £uorogenic substrate (£uorescein-dArGdAdAd-TAMRA;
Integrated DNA Technologies) hydrolysis were made using Perkin-
Elmer LS-50B £uorescence spectrophotometer. Ribonuclease^barnase
or RNAse Sa3 was combined with inhibitor at varying concentrations
and the rate of substrate hydrolysis was measured by monitoring the
increase in £uorescence (excitation 489 nm, emission 519 nm). The
experimental data were ¢t to a series of curves computed according to
the equation [14,15]:





where v is the initial reaction velocity at inhibitor concentration [I], v0
is the initial reaction velocity in the absence of inhibitor, [E] is con-
centration of ribonuclease and K, the dissociation constant, is the
estimated parameter. Estimation of the dissociation constant Kd was
done for every curve as determined from the best ¢t by non-linear
regression.
3. Results and discussion
3.1. Cloning a gene of RNase St inhibitor
Our ¢rst attempts to clone the gene of RNase St inhibitor
using heterologous DNA probes or degenerated synthetic oli-
gonucleotide probes by low stringency hybridization failed
(data not shown) as a consequence of rather low homology
(Fig. 1) among the family of bacterial ribonuclease inhibitors.
The most signi¢cant similarity in the multiple sequence align-
ment is observed in the small region, underlined in barstar,
which is known to be responsible for binding to ribonuclease.
The sequence of the rest of the inhibitor molecules appears to
be more diverse. Phage display technology o¡ers an alterna-
tive approach. Speci¢c clones carrying an inhibitor gene can
be selected from a whole genome library via an in vitro a⁄n-
ity selection of phage with the products of genes inserted into
the phage genome displayed on its surface. Immobilized ribo-
nuclease is used as the capturing ligand. We worked with a T7
phage display system which had already been successfully
tested in our laboratory for protein folding studies [12]. A
phage display library was constructed by shotgun cloning of
fragmented chromosomal DNA from S. erythraea. The result-
ing library consisted of 1.2U106 clones and had a titer
2.5U1010 pfu ml31, which together was expected to display
all proteins encoded by the sacchcaroplyspora genome in the
form of polypeptides of corresponding size. Since RNase St
was not available in quantities required for biopanning experi-
ments, barnase and RNase Sa3, homologs of RNase St, were
used as target ligands. Both enzymes, together with unrelated
protein bovine serum albumin as a control, were immobilized
on Iontosorb AV. These columns had performed well in af-
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¢nity puri¢cation of ribonuclease inhibitors from S. aureofa-
ciens [2]. Since a positive control experiment, using phage with
displayed barstar diluted to 1036, showed a signi¢cant enrich-
ment of binding phage in population of phages eluted from
a⁄nity columns (62%) after only six rounds (data not shown),
panning was repeated six times. The phage recovered after the
¢nal round were plated out to obtain individual clones for
sequencing. The displayed fragment was ampli¢ed by PCR
and sequenced. Although pilot experiments with yrdF ^ ribo-
nuclease inhibitor from Bacillus subtilis (data not shown) ^
con¢rmed observations that a DNA fragment can be dis-
played on the phage surface even if there is a shift in reading
frame between the inserted DNA and the capsid phage pro-
tein [16,17], the sequences were translated in three possible
frames and a search for homology between putative protein
and the family of bacterial inhibitors was performed using the
program Clustal W. Among 30 randomly picked phage after
six rounds of selection on barnase, none showed any homol-
ogy with RNase inhibitors, although some of the phage were
identical, suggesting that some sort of selection had taken
place. On the other hand, two out of eight clones randomly
picked from a pool of phage selected on RNase Sa3 were
identical and their translated sequence shows signi¢cant ho-
mology with other ribonuclease inhibitors (Fig. 1).
   
    
     
     
   
   
      
      
     













    
    
    
  
    
    
    
    
 
    
Fig. 1. Amino acid sequences of barstar ribonuclease inhibitor homologs. Sti ^ from Saccharopolyspora erythraea ; barstar ^ from Bacillus amy-
loliques ; yrdf ^ from Bacillus subtilis ; sai14 and Sai20 ^ from Streptomyces aureofaciens ; s. coelicolor ^ putative inhibitors from Streptomyces
coelicolor ; yersinia ^ from Yersinia pestis ; clostridium and clostridium 2 ^ from Clostridium acetobutylicum. Conserved amino acid residues are
expressed by shaded letters. Underlined amino acid of barstar indicate the chief contact region with barnase.
Fig. 2. Proposed mRNA secondary structure of Sti gene variants in the initiation region of protein synthesis. A: Wild-type Sti gene with
Shine-Dalgarno sequence (SD). Shine-Dalgarno sequence and initiation codon (ATG) are marked. Stability of helical structure in this region is
vG=322.3 kcal/mol. B: Structure of mRNA upon introduction of silent mutations into Sti gene. Stability of helical region is vG=310.5 kcal/
mol.
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Using the gene (Sti, GenBank accession number
AY374309) for this inhibitor homolog as a Southern hybrid-
ization probe, we re-isolated and sequenced the gene from a
subgenomic plasmid library, ensuring that no errors had been
introduced during PCR or phage replication and that we had
the correct 5P sequence. Several potential translation initiation
codons were identi¢ed, and the GTG codon which is preceded
by the plausible Shine-Dalgarno sequence GAAGGAG [18]
was assumed to be the translation start of the Sti gene. Codon
usage of the Sti gene is consistent with patterns found in the
related Streptomycetes genes, with 95% of codons having G or
C in the third position and an overall G+C content of 70.8%.
Analysis and comparison of both sequences, that from the
displayed fragment and that from the positive clone from
the plasmid library, con¢rmed that the whole Sti protein
was displayed on the phage surface.
3.2. Overexpression of Sti gene ^ alteration of mRNA
secondary structure
Using newly constructed restriction sites, the ampli¢ed Sti
gene was placed into the E. coli pET 28a expression vector
that contains a T7 promoter, which is activated by the pro-
duction of T7 polymerase. The level of Sti production was
monitored by checking the ability to inhibit barnase or RNase
Sa3 and by SDS^polyacrylamide gel electrophoresis (PAGE).
However, neither test revealed a presence of inhibitor protein
upon induction. Variation in cultivation conditions (E. coli
strain, temperature, medium, time and concentration of
IPTG) did not a¡ect the expression level of inhibitor. We
also tried the pTrc99A expression vector, which contains
IPTG inducible Trc promoter, without any success (data not
shown). We then considered the possibility that our di⁄culty
might be due to the low e⁄ciency of translation of Sti gene’s
mRNA in E. coli. That the problem was rare codon usage was
rejected, since there are only three codons in our gene which
are rarely used in E. coli and these were not near the 5P end
where they tend to be most damaging [19^21].
Another cause of low e⁄ciency of translation of heterolo-
gous genes in E. coli, as shown in numerous reports [22^25], is
formation of secondary structures in the mRNA, especially
when such structure includes parts of the Shine-Dalgarno se-
quence and/or the start codon. We did identify, using the
mfold program [13], such a potential structure in the start
region of the Sti mRNA. A complementary sequence, which
can form a very stable structure with the N-terminal region of
the inhibitor gene with minimum free energy 322.3 kcal/mol,
partially covering the translation initiation codon, was de-
tected down the coding sequence (Fig. 2). To attenuate this
helix structure by preventing base pairing, we consecutively
introduced silent mutations in di¡erent positions downstream
from the translation start site of the Sti gene (Fig. 3). Finally
Sti protein was e⁄ciently produced from an improved gene
with all the alterations shown. The di¡erence was even more
dramatic after we subcloned the same gene into a pET Blue-2
vector, a high copy version of pET vectors (Fig. 4). Since we
did not ¢nd any signi¢cant di¡erences at the transcription
level between wild-type and improved genes as assayed by
Northern hybridization, we conclude that the presence of un-
favorable mRNA secondary structure strongly suppresses the
expression rate of Sti protein from its wild-type gene in E. coli.
Presumably the source organism has mechanisms to amelio-
rate this problem, which it must face more often because of
the high G/C content of its DNA.
3.3. Puri¢cation and characterization of Sti inhibitor
Sti protein was fully soluble and puri¢ed by two sequential
procedures ^ anion exchange chromatography on HiPrep Q
XL Sepharose and size exclusion chromatography on Super-
dex-75. We obtained highly puri¢ed protein as judged by
SDS^PAGE. One puri¢cation yielded approximately 40^60
mg of pure protein from 1000 ml culture. Inhibition constants
Kd for the complexes Sti^RNase Sa3 and Sti^barnase were
estimated by enzyme titration with inhibitor as described in
Section 2 as 5U10312 or 7U1037, respectively (Fig. 5). Inter-
action of Sti^Sa3 is almost ¢ve orders of magnitude tighter
than that between Sti and barnase, the Sti^barnase complex
being the weakest observed among all such pairs. As noted
above, we can assume that di¡erences in the shape of active
sites between RNase St and barnase and in the distribution of
their charged residues on the surface cause low a⁄nity of
barstar to RNase St as indicated by the poor protection pro-
vided by barstar against the toxic e¡ects of RNase St. Since
Fig. 3. Silent mutations (shaded bases) introduced into the Sti gene by site-directed mutagenesis. Dotted underline marks Shine-Delgarno se-
quence, and solid underline marks the start codon.
Fig. 4. SDS^PAGE of recombinant Sti protein. Lane 1: bacterial ly-
sate of E. coli BL21 transformed with pET28a; lane 2: bacterial ly-
sate of E. coli BL21 transformed with pETSti; lane 3: bacterial ly-
sate of E. coli BL21 transformed with pETStimut6; lane 4: puri¢ed
Sti protein; lane 5: Multimark, molecular mass protein standards
(Invitrogen); lane 6: bacterial lysate of E. coli Turner transformed
with pETBlue-2; lane 7: bacterial lysate of E. coli Turner trans-
formed with pETBlueSti; lane 8: bacterial lysate of E. coli Turner
transformed with pETBlueStimut6; lane 9: puri¢ed Sti protein.
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Sti, as a natural inhibitor of RNase St, has evolved to inhibit
this particular ribonuclease, it is not surprising that the recip-
rocal combination, barnase to Sti, is also weakly bound for
the same reasons.
Our attempts to improve expression of RNase St in the
presence of Sti inhibitor have been disappointing. Production
of active protein has been increased two to three times (data
not shown), but yield is still rather low and there are appar-
ently some other intricacies in addition to the toxicity of this
enzyme. Work on this is in progress.
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